The pharmaceutical industry is on the cusp of a transformative era with the advent of Artificial Intelligence (AI). This paper delves into the multifaceted implications of AI in the pharmaceutical sector, encompassing aspects from manufacturing process improvements to drug discovery and personalized medicine. It explores AI’s role in reshaping business models, enhancing efficiency, and overcoming traditional challenges in drug development. Additionally, the paper addresses the challenges in adopting AI, such as the need for advanced IT infrastructure and handling unstructured data, underlining the potential of AI to revolutionize pharmaceutical practices.
No takes yet. Share an insight, caveat, or question.
Rakočević et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: